{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T19:06:31Z","timestamp":1761937591189,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1053\/j.seminhematol.2005.05.011","type":"journal-article","created":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T15:38:13Z","timestamp":1124293093000},"page":"S15-S21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S3","title":["Evolving Management Strategies for Heparin-Induced Thrombocytopenia"],"prefix":"10.1053","volume":"42","author":[{"given":"Lawrence","family":"Rice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2005.05.011_bib1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1001\/archinte.164.18.1961","article-title":"Heparin-induced thrombocytopenia","volume":"164","author":"Rice","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib2","series-title":"Heparin-Induced Thrombocytopenia","first-page":"53","article-title":"Clinical picture of HIT","author":"Warkentin","year":"2004"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib3","series-title":"Heparin-Induced Thrombocytopenia","first-page":"107","article-title":"Frequency of heparin-induced thrombocytopenia","author":"Lee","year":"2004"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2005.05.011_bib5","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"year":"2005","series-title":"Heart Disease and Stroke Statistics\u20142005 Update","key":"10.1053\/j.seminhematol.2005.05.011_bib6"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib7","first-page":"P1161","article-title":"Trends in incidence and diagnosis of heparin-induced thrombocytopenia at a tertiary medical center","volume":"1","author":"Francis","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2796.1999.00527.x","article-title":"Heparin-induced thrombocytopenia (HIT) due to heparin flushes","volume":"246","author":"Kadidal","year":"1999","journal-title":"J Int Med"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib9","first-page":"331","article-title":"Can heparin cause clotting?","volume":"10","author":"Rice","year":"1981","journal-title":"Heart Lung"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2005.05.011_bib10","first-page":"339a","article-title":"Heparin-induced thrombocytopenia\/thrombosis syndrome","volume":"68","author":"Rice","year":"1986","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","article-title":"Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia","volume":"106","author":"Wallis","year":"1999","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.CIR.99.1.73","article-title":"Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia","volume":"99","author":"Greinacher","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib14","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulation therapy in patients with heparin-induced thrombocytopenia","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0609.2004.00224.x","article-title":"Acute cardiorespiratory collapse from heparin","volume":"72","author":"Mims","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-136-3-200202050-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia","volume":"136","author":"Rice","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7326\/0003-4819-135-8_Part_1-200110160-00009","article-title":"Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archinte.164.1.66","article-title":"Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia","volume":"164","author":"Srinivasan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib19","series-title":"Heparin-Induced Thrombocytopenia","first-page":"335","article-title":"Treatment of heparin-induced thrombocytopenia","author":"Greinacher","year":"2004"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2005.05.011_bib20","doi-asserted-by":"crossref","first-page":"265S","DOI":"10.1378\/chest.126.3_suppl.265S","article-title":"New anticoagulant drugs","volume":"126","author":"Weitz","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-3848(03)00336-0","article-title":"Management of heparin-induced thrombocytopenia","volume":"110","author":"Warkentin","year":"2003","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mcp.2002.124522","article-title":"Bivalirudin pharmacokinetics and pharmacodynamics","volume":"71","author":"Robson","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0038-1651573","article-title":"Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans","volume":"69","author":"Fox","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib26","first-page":"611","article-title":"The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study","volume":"15","author":"Mahaffey","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib27","first-page":"1969","article-title":"Bivalirudin treatment of heparin-induced thrombocytopenia","volume":"102","author":"Berilgen","year":"2003","journal-title":"Blood"},{"unstructured":"Rice L, Nguyen P, Berilgen J, et al: Bivalirudin for very ill patients with heparin-induced thrombocytopenia. (manuscript in preparation)","key":"10.1053\/j.seminhematol.2005.05.011_bib28"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3810\/pgm.2002.09.1307","article-title":"Preventing complications in heparin-induced thrombocytopenia","volume":"112","author":"Rice","year":"2002","journal-title":"Postgrad Med"},{"key":"10.1053\/j.seminhematol.2005.05.011_bib30","series-title":"Heparin-Induced Thrombocytopenia","first-page":"573","article-title":"Legal aspects of heparin-induced thrombocytopenia","author":"McIntyre","year":"2004"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196305000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196305000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:15:06Z","timestamp":1758521706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196305000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":30,"alternative-id":["S0037196305000715"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2005.05.011","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving Management Strategies for Heparin-Induced Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2005.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}